AI Visibility Audit — geneonline.news

GeneOnline (基因線上) is an influential Asian biomedical media platform providing real-time global news, deep-dive industry analyses, and scientific literature tracking. Managed by a multinational team spanning the US, Taiwan, Canada, and Japan, it delivers cutting-edge insights to clinicians, biotechnology professionals, and the media.

About

The platform specializes in translating complex genomic and biopharmaceutical advancements into accessible insights, covering fields like precision medicine, cell therapy, clinical trials, and medical devices.

Target Audience

It targets medical doctors, clinical researchers, biotechnology professionals, venture capitalists, and general audiences interested in biomedical science and industry updates.

Highlights

• Delivers comprehensive coverage on clinical trials, precision medicine, and gene therapy across major markets in North America and Asia.
• Features high-profile scientific achievements, such as South Korea's Gil Hospital's innovative 'Kang's Repair' hernia surgery and the 7th Tang Prize in Biopharmaceutical Science.
• Bridges Asian and global biomedical developments through an international network spanning Taiwan, the US, Canada, and Japan.
• Operates the BIODND platform, offering international editions and promotional opportunities for biomedical ventures.

AI Search Strengths

• Broad AI crawler compatibility, allowing access to major agents including GPTBot, ClaudeBot, PerplexityBot, and Google-Extended.
• Maintains fully accessible XML sitemaps to ensure timely indexing of fresh news and articles.
• Employs Organization and WebSite structured data to assist search crawlers in verifying publisher identity.
• Implements strong Open Graph meta-tags to optimize visual and textual snippets on sharing platforms.

Objective Results

GeneOnline functions as an authoritative biomedical media engine, covering high-impact global health events, international scientific awards, and breakthroughs in cell manufacturing. It actively maintains its global footprint by offering an international BIODND version and organizing events connecting medical experts across the US, Japan, and Taiwan.

AI Visibility Score:80

---

View the full audit report →